Ctt Pharmaceutical Holdings, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OQB
CTT Pharmaceutical Holdings, Inc. has filed an S-1/A amendment to register up to 6,250,000 shares of common stock for resale by RH2 Equity Partners, issued under an Equity Line of Credit.
OQB
CTT Pharmaceutical Holdings, Inc. has filed an amended S-1 registration statement to allow for the resale of up to 6,250,000 shares of common stock by RH2 Equity Partners, issued under an Equity Line of Credit.
OQB
CTT Pharmaceutical Holdings, Inc. has filed an amended S-1 registration statement to allow for the resale of up to 6,250,000 shares of common stock by RH2 Equity Partners, issued under a committed equity line of credit.
OQB
CTT Pharmaceutical Holdings, Inc. has filed an amended S-1 registration statement detailing the potential resale of up to 6,250,000 shares of common stock by RH2 Equity Partners.
OQB
CTT Pharmaceutical Holdings, Inc. filed an amended S-1 registration statement to facilitate a $10 million equity line of credit with RH2 Equity Partners.